Oberg

Comerica Incorporated Names Brian Goldman Chief Risk Officer

Retrieved on: 
星期四, 十一月 9, 2023

DALLAS, Nov. 9, 2023 /PRNewswire/ -- Comerica Incorporated (NYSE: CMA) today announced that Brian Goldman has been named Senior Executive Vice President and Chief Risk Officer, effective Dec. 4, 2023. Goldman will succeed Jay Oberg, Senior Executive Vice President and Chief Risk Officer, who is expected to retire in December 2024, following more than 32 years with Comerica. Oberg will remain a senior executive vice president at Comerica until his retirement.

Key Points: 
  • DALLAS, Nov. 9, 2023 /PRNewswire/ -- Comerica Incorporated (NYSE: CMA) today announced that Brian Goldman has been named Senior Executive Vice President and Chief Risk Officer, effective Dec. 4, 2023.
  • Goldman will succeed Jay Oberg, Senior Executive Vice President and Chief Risk Officer, who is expected to retire in December 2024, following more than 32 years with Comerica.
  • As Chief Risk Officer, Goldman will report directly to Comerica Chairman, President and Chief Executive Officer Curt Farmer, as well as to the Enterprise Risk Committee of the Comerica Incorporated Board of Directors.
  • Goldman was previously the Chief Risk Officer for the Operations Division before serving as Head of Enterprise Risk Management where he established the organization's Enterprise Risk Management framework.

Myriad Genetics Hires Five Senior Leaders to Advance Commercial Growth Plans

Retrieved on: 
星期一, 十二月 19, 2022

Marc Leighton recently joined Myriad as Senior Vice President (SVP) for Product Management.

Key Points: 
  • Marc Leighton recently joined Myriad as Senior Vice President (SVP) for Product Management.
  • He most recently served as the CMO and founding team member at Sema4 Holdings Corp.
    Lisa Olson-Coombe recently joined Myriad as VP of Lab Transformation.
  • They are all accomplished leaders who will each play an instrumental role in accelerating the growth of our commercial business forward and elevating our products to their full potential,” said Paul J. Diaz, president and CEO, Myriad Genetics.
  • “Their combined depth of experience in healthcare and respective areas of expertise will continue to enrich our strong foundation for long-term sustainable growth, profitability and innovation.”

MYND Life Sciences CEO Invited to Present at Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference

Retrieved on: 
星期一, 二月 1, 2021

VANCOUVER, BC, Feb. 1, 2021 /PRNewswire/ -MYND Life Sciences Inc. ("MYND") a life sciences company focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals, is pleased to announce its CEO is presenting at Canaccord Genuity Group Inc.'s ("Canaccord Genuity") upcoming conference; New Paradigms and Treatment Approaches in Mental Health .

Key Points: 
  • VANCOUVER, BC, Feb. 1, 2021 /PRNewswire/ -MYND Life Sciences Inc. ("MYND") a life sciences company focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals, is pleased to announce its CEO is presenting at Canaccord Genuity Group Inc.'s ("Canaccord Genuity") upcoming conference; New Paradigms and Treatment Approaches in Mental Health .
  • MYND CEO, Dr. Lyle Oberg will be presenting on February 3, 2021 at 10:30 A.M EST.
  • "We are incredibly excited to present at Canaccord's upcoming conference focussed on psychedelic and novel treatment approaches in mental health", stated Dr. Lyle Oberg, MYND's Chief Executive Officer.
  • The Company has confirmed access to Health Canada psilocybin research and development through licenses to Chief Science Officer, Dr. Wilfred Jefferies.

Oberg Industries and Swanson School of Engineering Extend Additive Manufacturing Research Partnership

Retrieved on: 
星期二, 九月 25, 2018

PITTSBURGH, Sept. 25,2018 /PRNewswire/ -- After a successful two-year inaugural collaboration, representatives from Oberg Industries and the University of Pittsburgh's Swanson School of Engineering have agreed to extend their research partnership.

Key Points: 
  • PITTSBURGH, Sept. 25,2018 /PRNewswire/ -- After a successful two-year inaugural collaboration, representatives from Oberg Industries and the University of Pittsburgh's Swanson School of Engineering have agreed to extend their research partnership.
  • "Oberg was one of our first corporate partners in additive manufacturing and we are excited to continue this relationship," said David Vorp, associate dean for research.
  • "My colleagues and I are grateful to Oberg Industries for being an inaugural partner and allowing us to better explore the potential for additive manufacturing."
  • Since 2014, additive manufacturing researchers at the Swanson School have attracted more than $10 million in grants from America Makes, the National Energy Technology Laboratory, the National Science Foundation, and Research for Advanced Manufacturing in Pennsylvania.

5 Free Secrets From Ben Oberg on How to Become a Millionaire Without a College Degree

Retrieved on: 
星期二, 七月 24, 2018

LOS ANGELES, July 24, 2018 /PRNewswire/ --25-year-old self-made millionaire and founder of Millionaire Mafia, Ben Oberg, has just launched his new cryptonaire program on his website.

Key Points: 
  • LOS ANGELES, July 24, 2018 /PRNewswire/ --25-year-old self-made millionaire and founder of Millionaire Mafia, Ben Oberg, has just launched his new cryptonaire program on his website.
  • Oberg has created a fail-proof system of getting individuals to where they want to be as long as they are willing to put in the hard work.
  • Oberg reveals that "by not being a victim to the system I have found myself debt-free, travelling the world, and making hundreds of thousands of dollars per year."
  • Once you put those goals down on paper, you are saying to yourself "this is something I'm going to achieve."